HDL THERAPEUTICS, INC. — Form D
HDL THERAPEUTICS, INC. of VERO BEACH, FL, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-04. The offering totals $50.0M, of which $3.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-03-04
- Form: D
- Accession: 0001567619-21-005639
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $3.4M
- Remaining: $46.6M
- Investors: 31
- Date of first sale: 2021-02-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-391267
Issuer
- Name: HDL THERAPEUTICS, INC.
- CIK: 0001569047
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 601 21ST STREET, VERO BEACH, FL, 32960
- Phone: 772-453-2770
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Bryan Brewer | Director | Vero Beach, FL |
| Michael Matin | Director | Vero Beach, FL |
| Dane Andreeff | Director | Newtown, PA |
| Michael Matin | Executive Officer | Vero Beach, FL |
| Gregg Sessa | Director | Vero Beach, FL |
| Bryan Brewer | Executive Officer | Vero Beach, FL |
Other filings by this issuer (6)
More